Novartis Details Plans to Lay Off up to 8,000 Amid Sweeping Restructuring

Novartis plans to lay off as many as 8,000 employees worldwide as it continues a years long transformation into a more streamlined company, a spokesperson confirmed in an email to BioPharma Dive. Novartis has already begun the process of consulting managers ahead of the layoffs in Switzerland and plans to “design and implement” the overall changes in the next few months, the spokesperson said. The company “is making good progress” on previously announced structural changes and has finished hiring most leadership teams around the world, a spokesperson said.